Table 2.
Characteristics of the nonlesional gastric mucosa of 84 patients with GD or GC arising in the histopathological background of MF-AG or CR-AG
| All patients MF-AG and CR-AG n = 84 (100%) | MF-AG n = 45 (53.6%) |
CR-AG n = 39 (46.4%) |
P | |
| Antral mucosa | ||||
| Acute inflammation | 19.0 | 28.9 | 7.7 | 0.0142 |
| Chronic inflammation | 57.1 | 80.0 | 30.8 | <0.0001 |
| Atrophy | 50.0 | 93.3a | 0.0 | <0.0001 |
| Intestinal metaplasia | 41.0 | 75.6 | 0.0 | <0.0001 |
| Presence of Hp | 1.3 | 2.3 | 0.0 | 0.3657 |
| Corpus mucosa | ||||
| Acute inflammation | 28.6 | 33.3 | 23.1 | 0.3023 |
| Chronic inflammation | 94.0 | 91.1 | 97.4 | 0.2245 |
| Severe corpus atrophy | 51.2 | 48.9 | 46.4 | 0.6523 |
| Intestinal metaplasia | 82.9 | 84.4 | 81.1 | 0.6889 |
| Pseudopyloric metaplasia | 47.8 | 46.2 | 50.0 | 0.7530 |
| Presence of Hp | 2.5 | 2.3 | 2.9 | 0.8703 |
Data expressed as % when not otherwise indicated.
AG, atrophic gastritis, CR, corpus-restricted; GC, gastric cancer; GD, gastric dysplasia; Hp, Helicobacter pylori; MF, multifocal.
a
3 (6.7%) of the 45 MF-AG patients without antral atrophy had antral intestinal metaplasia.